Abstract Body

Background:

15-40% of people with HIV (PWH) develop HIV associated Neurocognitive Impairment (HIV-NCI) despite viral suppression with ART. HIV-NCI is mediated, in part, by transmigration of infected CD14+CD16+ monocytes across the blood brain barrier (BBB), establishing a CNS viral reservoir. We showed that CD14+CD16+ monocytes from PBMC of PWH have increased transmigration across an in-vitro BBB model to CCL2, a chemokine elevated in the CNS of PWH. In a pilot study, we showed that CCR2, the receptor for CCL2, on CD14+CD16+ monocytes is associated with HIV-NCI. This study builds on these findings. Mechanisms by which CD14+CD16+ monocytes mediate HIV-NCI have not been characterized extensively or examined in detail longitudinally. During HIV infection some cells harbor viral DNA (HIV+), and others do not, but are exposed to viral factors (HIVexp). We hypothesize that transmigration of CD14+CD16+ monocytes, particularly HIV+ CD14+CD16+ monocytes, across the BBB contributes HIV-NCI pathogenesis in PWH on ART.

Methods:

In a longitudinal study, we examined the baseline visits of 54 participants. PWH on Tenofovir-Emtricitabine-based regimens for ≥ 3 mos were recruited by the Manhattan HIV Brain Bank to undergo 1H-MRS and neurocognitive evaluation at 2 timepoints, 24 mos apart. PBMC were isolated from participants at both timepoints. PBMC were added to an in-vitro BBB model to analyze CCL2-induced transmigration of monocytes and of HIV+ and HIVexp PBMC. We measured associations between transmigration and HIV-NCI status using Frascati Criteria. We evaluated associations between CCR2 on CD14+CD16+ monocytes and HIV-NCI. Cross-sectional data from the first timepoint are presented. We are not powered to stratify by sex. Statistical comparisons were done by Wilcoxon Rank Sum Test.

Results:

We showed that CD14+CD16+ monocytes from PWH with HIV-NCI transmigrated more than those from PWH with normal cognition at time 1 (p< 0.05). Transmigration was also higher in those with impairment in speed of information processing (p< 0.05) and working memory (p< 0.01). CCR2 was higher on CD14+CD16+ monocytes in those with HIV-NCI at time 1 (p< 0.05). These results will also be correlated with indices of neuronal health cross-sectionally and longitudinally. We will assess whether HIV+ PBMC transmigrate more than HIVexp cells and determine an association with HIV-NCI.

Conclusions:

Peripheral circulating CD14+CD16+ monocytes and their CCR2 expression are indicators of CNS dysfunction, even with successful viral suppression.